China Resources Pharmaceutical (HKG:3320) subsidiary CR Pharmaceutical Commercial issued 400 million yuan of bonds in China with a three-year term and a coupon rate of 1.93% per annum.
Net proceeds will be used to repay interest-bearing debt, according to a Thursday filing with the Hong Kong bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.